Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Obstetrics and Gynecology

Volume  7, Issue 1, Jan-Mar 2019, Pages 19-25
 

Original Article

Use of Intramyometrial Versus Intravenous Oxytocin of 10IU in Prevention of Postpartum Haemorrhage During Cesarean Section

Gomathy E1, Nikitha V2, Munikrishna M3

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijog.2321.1636.7119.4

Abstract

 Postpartum hemorrhage from uterine atony, a major global and local health burden, remains to be a leading cause of maternal mortality. Intravenous oxytocin infusion has become the conventional first-line drug in the active management of third stage of labor in most countries. This, however, has been associated with refractory uterine atony and major hemodynamic side effects; hence the need to explore on the possibility of a better alternative such as intramyometrial oxytocin administration. Objectives: To compare the efficacy of 10IU of Intramyometrial Oxytocin and 10IU of Intravenous Oxytocin in prevention of Postpartum Haemorrhage during Cesarean Section. Settings and Design: A prospective randomised control study was conducted in the department of obstetrics and gynaecology at R.L Jalappa Hospital, Kolar. Methods and Material: Blood loss was considered as the primary measure variable and uterine tone at 1 min and 5 min of oxytocin administration and diasystolic blood pressure at 1 min and 5 mins post oxytocin administration were secondary outcomes measured. Statistical analysis used: Descriptive analysis was carried out by mean and standard deviation for quantitative variables, frequency and proportion for categorical variables. Data was also represented using appropriate diagrams like bar diagram. Results: A total of 186 subjects were included in the study. A total of 92 intravenous and 94 intramyometrial were included in the final analysis. The mean blood loss in ml patient was 624.78±132.85 in intravenous oxytocin group and it was 455.85 ±119.5 in intramyometrial, with a mean difference of 168.93 (p value < 0.001), which was statistically significant. Conclusions: Intramyometrial oxytocin at the same dose as i.v. administration both initiate contractions at similar intervals post administration. Intramyometrial infusion has a better safety profile when assessed using fall in diastolic blood pressure. It also resulted in lesser blood loss when compare to intravenous oxytocin.

Keywords: Oxytocin; Post partum haemorrhage; cesarean section; uterine atony.


Corresponding Author : Gomathy E, Professor, Dept. of Obstetrics and Gynecology, Sri Devaraj URS Medical College, Kolar, Karnataka 563101, India.